Medicare approved the groundbreaking new cell-based gene therapy drug, Encelto, for use in the ambulatory surgical center setting, effective for claims with dates of service on or after October 1, 2025. This article details how to bill for…
Reserve your spot today! The Medicare Navigator Part B Billing series continues throughout the month of June. Join us to sharpen your skills and submit accurate claims. Upcoming sessions focus on claim compliance requirements and proper cla…
View this outline of key definitions, billing responsibilities, and claim submission requirements for referred laboratory services to ensure correct reporting, avoid duplicate billing, and maintain adherence to regulatory guidelines.